FindTrial
Sign In

Efficacy of Combined Naikan and Morita Therapies on Psychological Distress and Posttraumatic Growth in Patients with Advanced Cancer

Efficacy of Combined Naikan and Morita Therapies on Psychological Distress and Posttraumatic Growth in Patients with Advanced Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026691
Enrollment
Unknown
Registered
2019-10-18
Start date
2019-12-12
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Interventions

1:Naikan and Morita Therapies
2:no

Sponsors

Jilin Province People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. newly diagnosed advanced cancer patients; 2. aged older than 30 years; 3. with adequate stamina to complete the study.

Exclusion criteria

Exclusion criteria: 1. significant cognitive impairments; 2. physical limitations to participate.

Design outcomes

Primary

MeasureTime frame
distress thermometer;Posttraumatic Growth Inventory;—

Secondary

MeasureTime frame
distress thermometer problem list;—

Countries

China

Contacts

Public ContactXiangbei Han

Jilin Province People's Hospital

13074350863@163.com+86 13074350863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026